Drug-induced hypersensitivity syndromes are associated with a variety of different drugs and have been recognized for many years. In previous studies and case reports, we usually defined the syndrome as a triad of fever, skin rash, and single or multiple internal organ involvement that starts within 8 weeks after initiation of therapy.1- 4 However, the variable presentation with a wide variety of abnormal clinical and laboratory manifestations and the multitude of different synonyms used to describe this entity can make diagnosis or a literature search difficult and may contribute to the general unfamiliarity that physicians seem to have with this syndrome.
Schlienger RG, Shear NH. DIDMOHS: A Proposed Consensus Nomenclature for the Drug-Induced Delayed Multiorgan Hypersensitivity Syndrome—Reply. Arch Dermatol. 1998;134(7):876. doi:
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.